Morning Headlines 5/16/22
PatientIQ, a patient outcomes data and insights vendor, raises $20 million in a Series B funding round.
Amwell Announces Results for First Quarter 2022
Amwell announces Q1 results: revenue up 11%, EPS –$0.26 versus –$0.16, missing analyst expectations for both.
A randomized clinical trial finds that remote monitoring and financial incentives had no impact on readmissions or deaths among discharged heart failure patients.
What's happening with Farzad's FACA charge? Seems to have dropped out of the news? Sweetheart deal in the works?